Novel substituted pyrazinone derivatives for use in MCH-1 mediated diseases

Details for Australian Patent Application No. 2006328558 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Macritchie, Jacqueline; Alvarez-Escobar, Rosa Maria; Simpson, Donald; Dautzenberg, Frank Matthias; AlcazarVaca, Manuel Jesus; Oyarzabal Santamarina, Julen; Andres-Gil, Jose Ignacio; Martinez Gonzalez, Sonia

Agent Shelston IP

Pub. Number AU-A-2006328558

PCT Pub. Number WO2007/071646

Priority 05112616.7 21.12.05 EP

Filing date 18 December 2006

Wipo publication date 28 June 2007

International Classifications

C07D 241/20 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/497 (2006.01)

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071646 Priority application(s): WO2007/071646

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328559-Mooring system

2006328551-Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists